SCHEMBL7667658

SCHEMBL7667658

CN(C)S(=O)(=O)n1cnc(-c2ccc([N+](=O)[O-])cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
LMNA P02545 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
TLR2 O60603 2/20 0.48
TLR1 Q15399 2/20 0.48
CYP3A4 P08684 2/20 0.48
GAA P10253 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
CYP2C19 P33261 1/20 0.48
RAB9A P51151 5/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
APP P05067 1/20 0.41
CHEK1 O14757 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688500 0.80 TSHR (0.38) ALDH1A1LMNAGAARAB9AMAPT
SCHEMBL31040273 0.76 CA12 (0.42) ALDH1A1LMNACYP3A4GAACYP1A2
SCHEMBL2672411 0.75 ALDH1A1 (0.56) ALDH1A1LMNANPSR1TLR2TLR1
SCHEMBL7102328 0.73 CYP19A1 (0.37) ALDH1A1LMNACYP3A4CYP1A2CYP2D6
SCHEMBL7100452 0.70 KMT2A (0.44) ALDH1A1LMNACYP3A4GAACYP2D6
SCHEMBL7100881 0.70 ALDH1A1 (0.41) ALDH1A1NPSR1GAARAB9AMAPT
SCHEMBL17673651 0.69 RAB9A (0.53) ALDH1A1LMNANPSR1TLR2TLR1
SCHEMBL15378630 0.69 RAB9A (0.66) ALDH1A1LMNANPSR1TLR2TLR1
SCHEMBL3637203 0.69 JAK2 (0.48) AURKAJAK2FGFR1PRKACAKDR
SCHEMBL14937980 0.67 FAAH (0.61) ALDH1A1LMNANPSR1TLR2TLR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407132-B1 ANTIHISTAMINES, ANTIALLERGENS, ANTIASTHMATICS, ANTICONVULSANTS, AND ANTIDEPRESSANTS; SKIN RASH TREATMENT JAMES BLACK FOUNDATION LIMITED (GB) 2002-06-18 US disclosed